<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="https://scholar.dgist.ac.kr/handle/20.500.11750/1156">
    <title>Repository Community: null</title>
    <link>https://scholar.dgist.ac.kr/handle/20.500.11750/1156</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="https://scholar.dgist.ac.kr/handle/20.500.11750/60691" />
        <rdf:li rdf:resource="https://scholar.dgist.ac.kr/handle/20.500.11750/60409" />
        <rdf:li rdf:resource="https://scholar.dgist.ac.kr/handle/20.500.11750/60382" />
        <rdf:li rdf:resource="https://scholar.dgist.ac.kr/handle/20.500.11750/60373" />
      </rdf:Seq>
    </items>
    <dc:date>2026-09-20T14:26:19Z</dc:date>
  </channel>
  <item rdf:about="https://scholar.dgist.ac.kr/handle/20.500.11750/60691">
    <title>원심 밸브 제어장치</title>
    <link>https://scholar.dgist.ac.kr/handle/20.500.11750/60691</link>
    <description>Title: 원심 밸브 제어장치
Author(s): 김민석</description>
  </item>
  <item rdf:about="https://scholar.dgist.ac.kr/handle/20.500.11750/60409">
    <title>Deciphering the Heterogeneity of Cancer-Associated Fibroblasts in Prostate Cancer: From Stromal Biology to Clinical Translation</title>
    <link>https://scholar.dgist.ac.kr/handle/20.500.11750/60409</link>
    <description>Title: Deciphering the Heterogeneity of Cancer-Associated Fibroblasts in Prostate Cancer: From Stromal Biology to Clinical Translation
Author(s): Truong, Ho Trong Tan; Kwon, Whi-An; Woo, Hyeong Jung; Kim, Minseok S.; Tran, Nhu Quang; Joung, Jae Young
Abstract: Prostate cancer (PCa) progression and treatment resistance are driven by tumor-intrinsic mechanisms and adaptive remodeling of the tumor microenvironment, in which cancer-associated fibroblasts (CAFs) play a crucial role. Although CAF biology is increasingly recognized, a major translational gap remains: CAFs are highly heterogeneous, and comprise distinct functional states with divergent effects on disease progression, immune regulation, and therapeutic resistance. To bridge this gap, we synthesize evidence from single-cell and spatial transcriptomic studies, tissue-based pathology, liquid biopsy assays, and molecular imaging to construct an evidence-tiered, decision-oriented translational framework that connects stromal mechanisms, translational measurement strategies, and therapeutic interventions in PCa. Single-cell and spatial transcriptomic analyses have consistently identified multiple CAF programs, including matrix-remodeling, inflammatory, immunoregulatory, antigen-presenting, and therapy-imprinted states, each with distinct functional outputs and clinical correlates. Tissue-based readouts, including reactive stromal grade (RSG) and fibroblast activation protein (FAP) immunohistochemistry, provide practical proxies for stromal activation and correlate with disease-specific mortality and imaging phenotypes. Circulating CAFs (cCAFs) represent an emerging liquid biopsy modality for longitudinal stromal monitoring, although technical standardization is required before clinical implementation. FAP-targeted PET imaging and emerging dual prostate-specific membrane antigen (PSMA)/FAP-targeted theranostic strategies provide noninvasive tools for patient selection and response assessment, particularly in PSMA-discordant or tracer-heterogeneous disease. Androgen receptor (AR)-targeted therapy can reprogram stromal states toward resistance-promoting circuits, highlighting the dynamic and plastic nature of the CAF compartment. A state-based CAF framework organizes stromal biology into testable translational hypotheses rather than immediate clinical standards. RSG and FAP-based tissue or imaging readouts are practical markers of stromal activation, whereas spatial CAF-immune signatures and cCAF assays remain investigational and require assay harmonization and prospective validation. Future trials should pre-specify stromal biomarkers as enrichment or pharmacodynamic variables when matched to the intervention and should avoid treating CAFs as a uniform therapeutic target.</description>
    <dc:date>2026-04-30T15:00:00Z</dc:date>
  </item>
  <item rdf:about="https://scholar.dgist.ac.kr/handle/20.500.11750/60382">
    <title>전자약의 스크리닝 장치 및 이를 이용한 스크리닝 방법</title>
    <link>https://scholar.dgist.ac.kr/handle/20.500.11750/60382</link>
    <description>Title: 전자약의 스크리닝 장치 및 이를 이용한 스크리닝 방법
Author(s): 김운해; 김민석; 강현규</description>
  </item>
  <item rdf:about="https://scholar.dgist.ac.kr/handle/20.500.11750/60373">
    <title>세포, 미세입자 동시 분리 장치 및 그 방법</title>
    <link>https://scholar.dgist.ac.kr/handle/20.500.11750/60373</link>
    <description>Title: 세포, 미세입자 동시 분리 장치 및 그 방법
Author(s): 김민석; 김종만; 이승준
Abstract: 미세유동장치가 개시된다. 본 미세유동장치는 생물학적 시료가 수용되며, 그 내부에서 원심력에 의하여 시료가 제1 표적 물질 및 비표적 물질을 포함하는 제1 유체층과, 복수의 제2 표적 물질을 포함하는 제2 유체층으로 분리되는 시료 챔버, 미세 입자를 수용하며, 시료 챔버로부터 제1 유체층을 전달받아 미세 입자와 비표적 물질이 결합된 결합체를 형성하며 밀도차에 의해 결합체와 제1 표적 물질을 분리시키는 제1 분리 모듈 및 시료 챔버로부터 제2 유체층을 전달받아 밀도차에 의해 복수의 제2 표적 물질을 분리시키는 제2 분리 모듈을 포함한다.</description>
  </item>
</rdf:RDF>

